Three‐year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry-Reference-Cited by-同舟云学术

Three‐year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry

Published:2020-11-19 Issue:3 Volume:98 Page:511-519
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Lhermusier Thibault¹^ORCID,Carrie Didier¹,Cayla Guillaume²,Fajadet Jean³,Sainsous Joel⁴,Elhadad Simon⁵,Tarragano Francois⁶,Chevalier Bernard⁷,Ranc Sylvain⁸,Curinier Corentin⁹,Le Breton Herve¹⁰,Koning Rene¹¹,

Affiliation:

1. Service de Cardiologie Hôpital Rangueil, Centre Hospitalo Universitaire de Toulouse Toulouse France

2. Service de Cardiologie CHU de Nîmes Nîmes France

3. Département de Cardiologie Clinique Pasteur Toulouse France

4. Service de Cardiologie Clinique Rhône‐Durance Avignon France

5. Service de Cardiologie Centre hospitalier de Marne‐la‐Vallée Jossigny France

6. Service de Cardiologie Hôpital Américain Neuilly‐sur‐Seine France

7. Hôpital Privé Jacques‐Cartier Institut Cardiovasculaire Paris‐Sud, Ramsay‐générale de Santé Massy France

8. Service de Cardiologie Centre hospitalier Saint‐Joseph et Saint‐Luc Lyon France

9. Service de Cardiologie Centre hospitalier de Perpignan Perpignan France

10. Service de Cardiologie CHU de Rennes Rennes France

11. Département de Cardiologie Clinique Saint‐Hilaire Rouen France

Funder

Abbott Laboratories

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29369

Reference27 articles.

1. Long-Term Safety of Drug-Eluting and Bare-Metal Stents

2. 5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents

3. Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial

4. Very Long-Term (15 to 20 Years) Clinical and Angiographic Outcome After Coronary Bare Metal Stent Implantation

5. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry;Archives of Cardiovascular Diseases;2022-10

2. Two-stage degradation and novel functional endothelium characteristics of a 3-D printed bioresorbable scaffold;Bioactive Materials;2022-04